Repligen Corporation
RGEN
$111.49
$1.371.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.36% | 11.74% | 8.73% | 4.88% | 0.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.36% | 11.74% | 8.73% | 4.88% | 0.33% |
| Cost of Revenue | 10.70% | 10.91% | 4.85% | 0.07% | -2.40% |
| Gross Profit | 21.98% | 12.53% | 12.74% | 9.93% | 3.19% |
| SG&A Expenses | 20.55% | -2.62% | 5.53% | 11.40% | 9.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.65% | 6.19% | 5.68% | 4.78% | 2.36% |
| Operating Income | 27.75% | 143.11% | 82.00% | 6.37% | -23.69% |
| Income Before Tax | 330.75% | -65.31% | -152.37% | -154.45% | -147.67% |
| Income Tax Expenses | 986.85% | -86.42% | -98.62% | -98.94% | -107.20% |
| Earnings from Continuing Operations | 291.64% | 121.47% | -245.82% | -197.56% | -171.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 291.64% | 121.47% | -245.82% | -197.56% | -171.68% |
| EBIT | 27.75% | 143.11% | 82.00% | 6.37% | -23.69% |
| EBITDA | 18.21% | 48.16% | 30.16% | 7.31% | -5.94% |
| EPS Basic | 291.22% | 120.06% | -245.56% | -196.86% | -171.04% |
| Normalized Basic EPS | 21.06% | 63.64% | 38.36% | -9.60% | -36.27% |
| EPS Diluted | 283.88% | 106.99% | -259.00% | -201.69% | -173.93% |
| Normalized Diluted EPS | 20.79% | 63.79% | 38.62% | -8.92% | -35.53% |
| Average Basic Shares Outstanding | 0.53% | 0.53% | 0.52% | 0.45% | 0.39% |
| Average Diluted Shares Outstanding | 0.54% | 0.38% | -0.26% | -0.48% | -0.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |